Agilent Technologies, Inc. Q2 Fiscal Year 2024 Financial Performance Analysis

  • Agilent's earnings per share (EPS) of $1.05 fell short of the estimated $1.19, indicating a discrepancy between performance and market expectations.
  • Revenue for the period was $1.573 billion, slightly below the anticipated $1.582 billion, suggesting a challenging quarter.
  • The company's GAAP net income increased to $308 million, with a non-GAAP net income of $356 million, showcasing profitability adjustments.

Agilent Technologies, Inc. (NYSE:A) recently disclosed its financial performance for the second quarter of the fiscal year 2024, which ended on April 30, 2024. The company, known for its contributions to the life sciences, diagnostics, and applied chemical markets, reported earnings and revenue that provide a snapshot of its current financial health and operational efficiency. This report is crucial for investors and stakeholders to understand how Agilent is performing, especially in comparison to market expectations and its performance in the previous year.

On Wednesday, May 29, 2024, Agilent reported an earnings per share (EPS) of $1.05, which did not meet the estimated EPS of $1.19 set by analysts. This outcome indicates a discrepancy between the company's performance and market expectations. Additionally, Agilent's revenue for the period was $1.573 billion, slightly below the anticipated $1.582 billion. These figures suggest a challenging quarter for Agilent, as both top and bottom line numbers fell short of expectations.

Despite the shortfall in EPS and revenue, Agilent's financial health can be further understood through its reported GAAP net income for the quarter, which stood at $308 million, or $1.05 per share. This represents an increase from the $302 million, or $1.02 per share, reported in the same quarter of the previous year. The company's non-GAAP net income for the quarter was $356 million, or $1.22 per share, showcasing a more nuanced picture of its profitability when adjusting for specific items.

Agilent's financial ratios also offer insight into its market valuation and financial stability. With a price-to-earnings (P/E) ratio of approximately 34.32, the market values Agilent at over 34 times its earnings over the last twelve months. This high P/E ratio could indicate investor confidence in Agilent's future growth prospects. The company's debt-to-equity (D/E) ratio stands at 0.41, showing a moderate level of debt relative to equity, which suggests a balanced approach to financing its operations. Additionally, the current ratio of 2.15 indicates that Agilent has more than twice its current liabilities in current assets, pointing to a strong liquidity position.

In summary, Agilent Technologies' Q2 fiscal year 2024 earnings report reveals a mixed financial performance, with some metrics not meeting analyst expectations while others highlight the company's profitability and financial health. The detailed analysis of Agilent's earnings, revenue, net income, and financial ratios provides a comprehensive view of its current standing and future prospects in the competitive landscape of the life sciences and diagnostics sectors.

Symbol Price %chg
PRDA.JK 2730 0
DHR-PB 1261.26 0
LALPATHLAB.BO 2794.7 0
LALPATHLAB.NS 2796.3 0
A Ratings Summary
A Quant Ranking
Related Analysis

Agilent Beats Q4 Expectations but Posts Soft Guidance

Agilent Technologies (NYSE:A) reported fourth-quarter earnings that exceeded analyst expectations, but its fiscal 2025 guidance came in below projections.

For the quarter ending, Agilent posted adjusted earnings per share (EPS) of $1.46, surpassing the Street consensus estimate of $1.41. Revenue increased by 0.8% year-over-year to $1.70 billion, also beating the expected $1.67 billion. Despite the strong quarter, the company’s outlook dampened investor sentiment.

Agilent projected full-year fiscal 2025 adjusted EPS in the range of $5.54 to $5.61, falling short of the $5.66 analysts anticipated. Revenue guidance of $6.79 billion to $6.87 billion was roughly in line with the Street consensus estimate of $6.83 billion.

Looking ahead to the first quarter of 2025, Agilent forecast revenue between $1.65 billion and $1.68 billion, representing a range of -0.5% to +1.3% year-over-year growth. Adjusted EPS for the quarter is expected to fall between $1.25 and $1.28.

Agilent Beats Q4 Expectations but Posts Soft Guidance

Agilent Technologies (NYSE:A) reported fourth-quarter earnings that exceeded analyst expectations, but its fiscal 2025 guidance came in below projections.

For the quarter ending, Agilent posted adjusted earnings per share (EPS) of $1.46, surpassing the Street consensus estimate of $1.41. Revenue increased by 0.8% year-over-year to $1.70 billion, also beating the expected $1.67 billion. Despite the strong quarter, the company’s outlook dampened investor sentiment.

Agilent projected full-year fiscal 2025 adjusted EPS in the range of $5.54 to $5.61, falling short of the $5.66 analysts anticipated. Revenue guidance of $6.79 billion to $6.87 billion was roughly in line with the Street consensus estimate of $6.83 billion.

Looking ahead to the first quarter of 2025, Agilent forecast revenue between $1.65 billion and $1.68 billion, representing a range of -0.5% to +1.3% year-over-year growth. Adjusted EPS for the quarter is expected to fall between $1.25 and $1.28.

Agilent Technologies' Strong Q4 Financial Performance

  • Agilent Technologies (NYSE:A) reported earnings per share (EPS) of $1.46, surpassing the estimated $1.41.
  • The company's revenue for the quarter was approximately $1.7 billion, exceeding the estimated $1.67 billion.
  • Agilent's financial health is indicated by a price-to-earnings (P/E) ratio of 29.84 and a current ratio of 2.09.

Agilent Technologies (NYSE:A) is a prominent player in the electronics testing equipment industry. The company specializes in providing analytical instruments, software, services, and consumables for the entire laboratory workflow. Agilent's competitors include Thermo Fisher Scientific and Danaher Corporation. The company recently reported its financial results for the fourth quarter of fiscal year 2024, showcasing its strong performance.

On November 25, 2024, Agilent reported earnings per share (EPS) of $1.46, surpassing the estimated $1.41. This marks a 3.55% earnings surprise, as highlighted by Zacks. The company has consistently outperformed consensus EPS estimates over the past four quarters, demonstrating its ability to exceed market expectations. In the previous quarter, Agilent also reported a positive earnings surprise of 5.60%.

Agilent's revenue for the quarter was approximately $1.7 billion, exceeding the estimated $1.67 billion. This represents a 1.65% revenue surprise, according to Zacks. The company has surpassed consensus revenue estimates in three of the last four quarters. Despite a slight decline of 0.3% in core revenue compared to the same quarter in 2023, Agilent's reported revenue increased by 0.8%.

During the Q4 2024 earnings call, CEO Padraig McDonnell and CFO Bob McMahon discussed the company's financial performance and strategic direction. Agilent's new market-based, customer-first strategy and organizational transformation are expected to enhance growth opportunities. The call was attended by analysts from major financial institutions, including Citi, Goldman Sachs, JPMorgan, and Bank of America.

Agilent's financial metrics provide insight into its market valuation and financial health. The company's price-to-earnings (P/E) ratio is approximately 29.84, while its price-to-sales ratio stands at about 5.94. The enterprise value to sales ratio is around 6.25, and the enterprise value to operating cash flow ratio is approximately 22.79. Agilent's debt-to-equity ratio is about 0.57, and its current ratio is around 2.09, indicating a strong ability to cover short-term liabilities.

Agilent Technologies' Strong Q4 Financial Performance

  • Agilent Technologies (NYSE:A) reported earnings per share (EPS) of $1.46, surpassing the estimated $1.41.
  • The company's revenue for the quarter was approximately $1.7 billion, exceeding the estimated $1.67 billion.
  • Agilent's financial health is indicated by a price-to-earnings (P/E) ratio of 29.84 and a current ratio of 2.09.

Agilent Technologies (NYSE:A) is a prominent player in the electronics testing equipment industry. The company specializes in providing analytical instruments, software, services, and consumables for the entire laboratory workflow. Agilent's competitors include Thermo Fisher Scientific and Danaher Corporation. The company recently reported its financial results for the fourth quarter of fiscal year 2024, showcasing its strong performance.

On November 25, 2024, Agilent reported earnings per share (EPS) of $1.46, surpassing the estimated $1.41. This marks a 3.55% earnings surprise, as highlighted by Zacks. The company has consistently outperformed consensus EPS estimates over the past four quarters, demonstrating its ability to exceed market expectations. In the previous quarter, Agilent also reported a positive earnings surprise of 5.60%.

Agilent's revenue for the quarter was approximately $1.7 billion, exceeding the estimated $1.67 billion. This represents a 1.65% revenue surprise, according to Zacks. The company has surpassed consensus revenue estimates in three of the last four quarters. Despite a slight decline of 0.3% in core revenue compared to the same quarter in 2023, Agilent's reported revenue increased by 0.8%.

During the Q4 2024 earnings call, CEO Padraig McDonnell and CFO Bob McMahon discussed the company's financial performance and strategic direction. Agilent's new market-based, customer-first strategy and organizational transformation are expected to enhance growth opportunities. The call was attended by analysts from major financial institutions, including Citi, Goldman Sachs, JPMorgan, and Bank of America.

Agilent's financial metrics provide insight into its market valuation and financial health. The company's price-to-earnings (P/E) ratio is approximately 29.84, while its price-to-sales ratio stands at about 5.94. The enterprise value to sales ratio is around 6.25, and the enterprise value to operating cash flow ratio is approximately 22.79. Agilent's debt-to-equity ratio is about 0.57, and its current ratio is around 2.09, indicating a strong ability to cover short-term liabilities.

Agilent Technologies (NYSE:A) Quarterly Earnings Preview

  • The anticipated EPS of $1.41 represents a 2.2% increase from the previous year.
  • Projected revenue of $1.67 billion marks a slight decrease of 0.9% year-over-year.
  • Options markets are pricing in a potential stock swing of 7.6% post-earnings.

Agilent Technologies (NYSE:A) is a global leader in life sciences, diagnostics, and applied chemical markets. The company provides instruments, software, services, and consumables for the entire laboratory workflow. As Agilent prepares to release its quarterly earnings on November 25, 2024, analysts expect an earnings per share (EPS) of $1.41 and revenue of $1.67 billion.

The anticipated EPS of $1.41 represents a 2.2% increase from the previous year, as highlighted by analysts. However, the projected revenue of $1.67 billion marks a slight decrease of 0.9% year-over-year. This stability in earnings estimates over the past 30 days suggests that analysts are confident in their forecasts, which can influence investor sentiment.

Historically, Agilent's stock has shown mixed reactions following earnings reports, with an equal number of positive and negative next-day returns over the past eight quarters. On average, the stock has moved 5.3% in either direction post-earnings in the last two years. However, options markets are currently pricing in a larger potential swing of 7.6% this time.

Agilent's stock price is currently up 0.9% at $126.83, recovering from its lowest close since July and potentially ending a four-day losing streak. The company's financial ratios, such as a P/E ratio of 27.10 and a price-to-sales ratio of 5.84, reflect investor confidence in its earnings and revenue potential. The debt-to-equity ratio of 0.50 indicates a moderate level of debt, while a current ratio of 1.78 suggests good liquidity.

Agilent Technologies (NYSE:A) Quarterly Earnings Preview

  • The anticipated EPS of $1.41 represents a 2.2% increase from the previous year.
  • Projected revenue of $1.67 billion marks a slight decrease of 0.9% year-over-year.
  • Options markets are pricing in a potential stock swing of 7.6% post-earnings.

Agilent Technologies (NYSE:A) is a global leader in life sciences, diagnostics, and applied chemical markets. The company provides instruments, software, services, and consumables for the entire laboratory workflow. As Agilent prepares to release its quarterly earnings on November 25, 2024, analysts expect an earnings per share (EPS) of $1.41 and revenue of $1.67 billion.

The anticipated EPS of $1.41 represents a 2.2% increase from the previous year, as highlighted by analysts. However, the projected revenue of $1.67 billion marks a slight decrease of 0.9% year-over-year. This stability in earnings estimates over the past 30 days suggests that analysts are confident in their forecasts, which can influence investor sentiment.

Historically, Agilent's stock has shown mixed reactions following earnings reports, with an equal number of positive and negative next-day returns over the past eight quarters. On average, the stock has moved 5.3% in either direction post-earnings in the last two years. However, options markets are currently pricing in a larger potential swing of 7.6% this time.

Agilent's stock price is currently up 0.9% at $126.83, recovering from its lowest close since July and potentially ending a four-day losing streak. The company's financial ratios, such as a P/E ratio of 27.10 and a price-to-sales ratio of 5.84, reflect investor confidence in its earnings and revenue potential. The debt-to-equity ratio of 0.50 indicates a moderate level of debt, while a current ratio of 1.78 suggests good liquidity.